Monkeypox is a rare viral disease that affects both humans and animals. The virus is part of the Orthopoxvirus family, which also includes smallpox, cowpox, and vaccinia viruses. Although monkeypox is not as severe as smallpox, it can cause serious illness and has a mortality rate of 1 to 10% in Africa.
Monkeypox was first identified in 1958 when outbreaks occurred in monkeys kept for research purposes in Copenhagen and London. In 1970, the first human case was reported in the Democratic Republic of Congo (DRC). Since then, monkeypox has been reported in other African countries such as Cameroon, Central African Republic, Liberia, Nigeria, Republic of the Congo, Sierra Leone, and Sudan. In 2003, the first cases of human monkeypox were reported outside of Africa, in the United States, after an outbreak linked to pet prairie dogs imported from Ghana.
The virus is primarily spread through contact with infected animals, such as rodents, squirrels, monkeys, and other primates, or through contact with bodily fluids from infected animals. The virus can also be transmitted from person to person through respiratory droplets, contact with bodily fluids, or contact with contaminated objects. The incubation period is typically 5 to 21 days, and symptoms usually last for 2 to 4 weeks.
The symptoms of monkeypox are similar to those of smallpox, but generally milder. The disease usually starts with a fever, headache, muscle aches, and fatigue. After a few days, a rash develops, which typically begins on the face and then spreads to the trunk and limbs. The rash progresses to pustules, which eventually scab over and fall off. Lesions may also form in the mouth, throat, and genitals. Lymph nodes often become swollen and painful, and some patients may develop pneumonia.
There is no specific treatment for monkeypox, and supportive care is the mainstay of management. Pain relief medication and antipyretics may be given to relieve fever and pain. In severe cases, patients may need to be hospitalized, and antibiotics may be prescribed to treat secondary bacterial infections.
Prevention of monkeypox is mainly through vaccination, and the smallpox vaccine is believed to provide some protection against monkeypox. However, the smallpox vaccine is no longer available to the general public since smallpox has been eradicated. In affected areas, preventive measures such as wearing protective clothing and practicing good hand hygiene may help reduce the risk of infection.
In conclusion, monkeypox is a rare but potentially serious viral disease that primarily affects people in central and West African countries. Although the disease is not as severe as smallpox, it can cause significant morbidity and mortality. Early recognition and diagnosis of the disease are important to prevent its spread, and vaccination against smallpox may provide some protection.
Looking for Monkeypox detection kits?
High quality kits can be found here
- High quality Monkeypox Virus RT-PCR | GEN-MPV-30
-
Monkeypox B5R
mpv-002 ProSpec Tany 100µg 200.00 EUR Monkeypox A33R
mpv-001 ProSpec Tany 100µg 200.00 EUR Monkeypox virus
Oneq-VH747-OneqVH747100D Bioingentech Oneq-VH747-100D 515.00 EUR Monkeypox virus
Oneq-VH747-OneqVH747150D Bioingentech Oneq-VH747-150D 594.00 EUR Monkeypox virus
Oneq-VH747-OneqVH74750D Bioingentech Oneq-VH747-50D 413.00 EUR Recombinant Monkeypox B5R
MBS141734-01mg MyBiosource 0.1mg 360.00 EUR Recombinant Monkeypox B5R
MBS141734-05mg MyBiosource 0.5mg 960.00 EUR Recombinant Monkeypox B5R
MBS141734-1mg MyBiosource 1mg 1565.00 EUR Recombinant Monkeypox B5R
MBS141734-5x1mg MyBiosource 5x1mg 6715.00 EUR Recombinant Monkeypox A33R
MBS141733-01mg MyBiosource 0.1mg 360.00 EUR Recombinant Monkeypox A33R
MBS141733-05mg MyBiosource 0.5mg 960.00 EUR Recombinant Monkeypox A33R
MBS141733-1mg MyBiosource 1mg 1565.00 EUR Recombinant Monkeypox A33R
MBS141733-5x1mg MyBiosource 5x1mg 6715.00 EUR EasyNAT Monkeypox Virus Assay
U202028 USTAR Biotechnologies (Hangzhou) test Ask for price Monkeypox Virus, 20 tests/kit
U202028-20 USTAR Biotechnologies (Hangzhou) test Ask for price